Opaleye Management Inc. → Protara Therapeutics, Inc. TARA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Moderate short days-to-cover (4.3 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.32

6,094,189 shares short · +5.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $150K

Point72 Asset Mgmt

Other 13D/G Filings on Protara Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2021-01-08	SC	Flynn James E	—	—	view →
2020-01-27	SC	Opaleye Management Inc.	—	—	view →
2020-01-17	SC	Flynn James E	—	—	view →
2020-01-17	SC	Abingworth LLP	—	—	view →
2019-11-14	SC	Flynn James E	—	—	view →
2019-11-14	SC	Abingworth LLP	—	—	view →
2019-11-08	SC	Flynn James E	—	—	view →

Other Filings by Opaleye Management Inc.

Filed	Form	Issuer	Stake	Shares
2026-07-24	SCHEDULE 13G/A	Alpha Cognition Inc.	—	—	view →
2026-06-29	SCHEDULE 13G/A	Alpha Cognition Inc. ACOG	—	—	view →
2020-01-27	SC	ArTara Therapeutics, Inc. TARA	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →